Preamble: Why This Conversation Matters
Golden Retrievers are beloved family companions-intelligent, gentle, naturally suited to children and multi-dog households. They are also, as a breed, genetically predisposed to certain cardiac conditions that families and breeders should understand clearly and honestly. This is not a reason to avoid the breed. It is a reason to choose breeders and veterinarians who screen methodically and communicate transparently.
The most significant cardiac concern in Golden Retrievers is subaortic stenosis (SAS)-a narrowing of the passage beneath the aortic valve that forces the heart to work harder to pump blood. The condition exists on a spectrum: some dogs never develop clinical signs and live normal lifespans; others deteriorate progressively; a small percentage experience sudden, fatal arrhythmias. What makes SAS particularly important for families to understand is that it is congenital-present from birth, though the severity and progression vary-and that a parent dog's mildness does not predict offspring outcomes. A dog with no detectable SAS can have puppies with severe disease. Conversely, a dog with mild SAS might produce puppies with no disease at all.
We mention diet-associated heart disease as well because families will encounter discussions about grain-free diets and dilated cardiomyopathy (DCM) online. That evidence base is genuinely contested, evolving, and deserves honest treatment rather than confident assertions in either direction.
This document serves several purposes. It explains what these cardiac conditions actually are-not in jargon that requires a veterinary degree to parse, but in functional terms that help families understand what's happening inside the heart and why screening matters. It describes the difference between a quick listen with a stethoscope and the specialized testing that can actually quantify cardiac disease. It acknowledges the limitations of screening-what it can and cannot tell us. And it describes how Just Behaving approaches cardiac evaluation as part of responsible breeding.
One fundamental principle undergirds everything that follows: health screening is not a guarantee. It is a risk reduction strategy. No responsible breeder can promise a heart-healthy dog. What a responsible breeder can do is screen rigorously using gold-standard methodology, remove high-risk dogs from breeding, apply the results of screening transparently, and work with families to watch for warning signs across the dog's lifespan. A puppy's heart does not exist in isolation from the world it enters. But neither does a breeder's commitment to the dog's health end at the curb. That commitment is foundational to everything the Five Pillars describe. A puppy whose heart will fail at three years old cannot be raised into a well-mannered, functional family member. Health screening is the biological prerequisite.
Chapter 1: Subaortic Stenosis-The Primary Cardiac Concern in Golden Retrievers
What SAS Actually Is
To understand subaortic stenosis, picture the left side of the heart as a pump with a valve. The left ventricle (the heart's main pumping chamber) contracts and pushes blood upward through the aortic valve and into the aorta, the large artery that distributes blood throughout the body. In a normal heart, this passage is smooth and unobstructed. In subaortic stenosis, abnormal fibrous and muscular tissue grows in the left ventricular outflow tract-the area just below the aortic valve. This tissue narrows the passage, creating a functional obstruction.
The consequence is mechanical: the left ventricle must generate higher pressures to push blood through a narrower opening. Imagine forcing the same volume of water through a pipe that has been partially blocked. The pump behind it works harder. Over time, chronic pressure overload causes the left ventricular wall to thicken (a condition called left ventricular hypertrophy). Thickened muscle becomes stiffer and less efficient. The heart struggles to relax between beats, reducing its ability to fill with blood. In severe cases, this progressive damage can lead to heart failure-the heart can no longer meet the body's needs-or to electrical instability, putting the dog at risk for dangerous arrhythmias, including sudden cardiac death.
What makes SAS particularly important in Golden Retrievers is that the condition is congenital. The dog is born with it. The severity of the narrowing present at birth appears to be inherited, though the pattern of inheritance is complex: pedigree analysis in Golden Retrievers strongly supports an autosomal recessive mode of inheritance, though polygenic modifiers likely influence ultimate severity (Stern et al., 2012). [Documented - Dog - Golden Retriever] In practical terms, this means two parents with mild disease can produce puppies with severe disease, and two parents with no detected disease can produce puppies with SAS. Screening removes high-risk dogs from breeding, but does not-and cannot-eliminate the condition.
How Common Is It?
Prevalence estimates for SAS vary dramatically depending on the population studied. In a large veterinary referral hospital study examining 80,943 unique dogs, Golden Retrievers had an odds ratio of 10.67 compared to the general hospital population, with an observed prevalence of 1.42% in Golden Retrievers specifically. [Documented - Dog - Golden Retriever] This figure deserves scrutiny: referral hospitals treat dogs sick or sick enough to warrant specialist evaluation. Prevalence in a referral population is not the same as prevalence in the general population. That same study suggests the true breed prevalence is likely lower, though still meaningfully elevated compared to mixed-breed dogs. A reasonable interpretation is that SAS occurs in a meaningful but not dominant percentage of the breed.
Why does this matter for your family? If you're acquiring a Golden Retriever puppy, the risk that SAS will emerge is real but not catastrophic. The risk that a breeder failed to screen for it, or screened incompletely, is much higher.
Severity and Clinical Outcome
SAS exists on a spectrum. At one end, a dog might have subtle fibrous tissue below the aortic valve, produce no detectable heart murmur, cause no hemodynamic abnormality, and live a completely normal lifespan with no cardiac symptoms. These dogs are alive; they just happen to have the anatomical substrate for disease. At the other end, a dog might develop severe narrowing, progressive ventricular hypertrophy, heart failure symptoms (fatigue, exercise intolerance, shortness of breath), and risk of sudden fatal arrhythmia.
A pivotal study of 195 dogs with naturally occurring SAS found that 21.9% died suddenly, predominantly in the first three years of life. [Documented - Dog - General] This figure includes dogs across the full severity spectrum and likely reflects cases diagnosed or managed without specialist care. Dogs with mildly elevated outflow velocities have very different prognoses than dogs with severe obstruction. A dog with a peak aortic velocity of 1.8 m/s (borderline elevated) has a different future than a dog with a velocity of 3.5 m/s (severely obstructed). The ability to measure and grade severity is precisely why echocardiographic screening matters.
Why Parents' Phenotype Does Not Predict Offspring Phenotype
This is perhaps the most important single fact for families to understand: a parent dog's severity does not predict a puppy's severity. Research in Golden Retrievers has examined the relationship between parental SAS phenotype and offspring outcomes, and the autosomal recessive inheritance pattern with polygenic modifiers means that the phenotypic severity of the parents does not reliably predict the phenotypic severity of the offspring (Stern et al., 2012). [Documented - Dog - Golden Retriever] Offspring of affected parents can have mild, moderate, or severe disease. Offspring of unaffected parents can be unaffected, or can develop SAS. A breeder cannot look at a parent dog and say with confidence, "My puppies will be fine." That is precisely why screening matters, and why a responsible breeder screens not just breeding stock but puppies and young dogs born in the program.
Chapter 2: Why the Stethoscope Is Not Enough
The Murmur Problem
Subaortic stenosis typically produces a heart murmur-an abnormal sound audible through a stethoscope. A clinician listens to the left heart base (the upper left side of the chest wall) and hears a systolic ejection murmur: a whooshing sound during the heart's contraction as blood turbulently crosses the narrowing. Many breeders rely on veterinary auscultation (listening with a stethoscope) as their primary screening tool. This approach has a critical limitation: the correlation between a veterinarian's ability to detect a murmur and the actual presence or severity of SAS is far weaker than most assume.
A landmark study examined agreement between general practitioners and board-certified veterinary cardiologists on murmur detection in clinically healthy puppies. The results were sobering: kappa = 0.01, essentially random agreement. [Documented - Dog - Multi-breed] Non-specialists and specialists were disagreeing about whether a murmur was even present-not disagreeing about severity, but about presence. Necropsy studies (examination of dogs after death) have documented dogs with obvious subvalvular fibrotic ridges on direct tissue examination that exhibited no detectable heart murmur during their lifetime clinical evaluations. [Documented - Dog - Multi-breed] In other words, a dog can have the anatomical substrate for disease-the abnormal tissue that will eventually cause problems-and produce no sound that a stethoscope can detect.
The inverse problem also exists: a dog with an innocent murmur (a sound caused by normal turbulent flow, not pathological narrowing) can alarm an overly cautious evaluator. Stress, anemia, hyperthyroidism, and other systemic conditions can produce murmurs unrelated to cardiac disease.
What Echocardiography Actually Measures
Doppler echocardiography-the application of ultrasound and Doppler physics to measure blood flow velocity-answers a question the stethoscope cannot: "What is the blood actually doing?" The technician applies ultrasound gel and moves an ultrasound probe across the chest wall, visualizing the heart's structures in real time and measuring the velocity of blood as it moves through the left ventricular outflow tract. The result is not subjective. It is quantifiable, reproducible, and gradable by severity.
In Doppler echocardiography, we measure peak aortic flow velocity-the fastest speed at which blood moves through the outflow tract during systole. A normal dog typically has a peak aortic velocity of approximately 1.0-1.5 m/s. [Documented - Dog - Golden Retriever] A dog with mild SAS might have a velocity of 2.0-3.0 m/s. A dog with severe SAS might have a velocity of 4.0 m/s or higher. The number correlates with the degree of obstruction, the likelihood of progressive disease, and the risk of clinical complications. A board-certified veterinary cardiologist examining these numbers, combined with structural findings on echo (thickness of the left ventricular wall, appearance of the mitral valve, chamber size), can grade severity and discuss prognosis.
This is not a perfect test. No cardiac screening test is. But it is categorically superior to auscultation alone because it measures physiology, not perception.
Chapter 3: The Equivocal Zone-Why Screening Isn't Simple
The Boundary Between Normal and Abnormal
In an ideal world, cardiac screening would produce binary results: normal or abnormal, healthy or affected. The actual world is messier. In a study of 214 healthy adult Golden Retrievers with no clinical signs of heart disease, the peak aortic flow velocity had a median of 1.51 m/s, with an upper reference limit of 2.2 m/s. [Documented - Dog - Golden Retriever] This means roughly 95% of healthy dogs fell below 2.2 m/s. But it also means a subset of completely healthy, normal dogs naturally approach or occasionally exceed 2.0 m/s. Where should the cutoff for "abnormal" be placed? Higher cutoffs reduce the false-positive rate but might miss early disease. Lower cutoffs catch more potential disease but increase the risk of incorrectly diagnosing normal dogs.
Different cardiologists and screening organizations use slightly different cutoffs. Some use 2.0 m/s; some use 2.4 m/s; some use a tiered system where 2.0-2.4 m/s is "borderline" and requires follow-up, while above 2.4 is "affected." This variation reflects genuine scientific uncertainty, not incompetence. It is a reminder that screening results should always be interpreted in clinical context by someone trained to recognize context.
The Stress Effect
Blood velocity measurements are sensitive to the dog's physiological state at the moment of examination. Emotional stress increases measured velocities. A study in Boxers (a breed also predisposed to SAS) found that 27 of 215 normal dogs would have been misdiagnosed as SAS-affected if a stress-associated cutoff had been applied to a single examination. [Documented - Dog - Boxer] [Application to Golden Retriever: Cross-species inference] Dogs that are anxious, fearful, or agitated during echocardiographic examination can produce artificially elevated flow velocities. A skilled cardiologist recognizes this possibility and either repeats the exam when the dog is calmer or interprets high velocities conservatively when stress is evident.
The Progression Problem
SAS is congenital-the dog is born with it. But the severity expressed phenotypically is often progressive during growth. Velocities can increase from puppyhood through young adulthood, even in dogs that initially measured in the normal range. Two studies of Golden Retrievers explicitly documented this progression: dogs screened as puppies sometimes developed increased aortic velocities at later re-examination. [Documented - Dog - Golden Retriever] This fact has profound implications for screening strategy. A single normal puppy exam does not safely rule out future SAS. A dog might screen as normal at eight weeks, borderline at six months, and clearly affected at two years.
Responsible screening programs therefore do not treat a single normal measurement as a lifetime clearance. They re-screen dogs periodically, particularly during the growth phase. They understand that borderline results demand follow-up, not dismissal. They recognize that a dog with a velocity of 1.8 m/s at four months might need re-examination at one year and two years of age.
Chapter 4: Diet-Associated Heart Disease-What We Know and Don't Know
Taurine-Responsive Dilated Cardiomyopathy
In recent years, veterinary cardiologists have documented cases of dilated cardiomyopathy (DCM)-enlargement and weakening of the left ventricle-in breeds not historically predisposed to the condition. Some of these cases showed improvement or resolution with diet changes and taurine supplementation. In Golden Retrievers specifically, a case series of 24 affected dogs showed significant improvement in cardiac function after dietary modification and taurine supplementation. [Documented - Dog - Golden Retriever] An earlier case series described a family of five related Golden Retrievers with similar DCM findings and similar response to taurine supplementation. [Documented - Dog - Golden Retriever]
Taurine is an amino acid essential for cardiac function. Dogs can synthesize taurine endogenously, but certain dietary patterns-particularly those high in certain legume-derived plant proteins and low in animal protein sources-may impair taurine bioavailability or increase urinary losses. When taurine deficiency becomes severe, the left ventricle can dilate and weaken, leading to heart failure. The good news is that in some cases, taurine supplementation and dietary change can reverse cardiac dysfunction.
The Grain-Free Diet Question
Beginning around 2018, the U.S. Food and Drug Administration began receiving reports of DCM in dogs fed grain-free, or high-legume-content, diets. By 2022, the FDA had tracked 1,382 or more reports of canine DCM potentially associated with diet. The agency's investigation explicitly states that adverse-event report numbers alone cannot establish a causal relationship between specific diets and DCM. [Documented - Dog - General] A dog fed a grain-free diet that develops DCM does not prove the diet caused the disease; correlation is not causation. However, the temporal relationship was noteworthy enough that the FDA continued investigating.
The broader causality question - whether grain-free or pulse-rich diets cause DCM in Golden Retrievers or other breeds - remains genuinely unresolved. [Ambiguous - Dog - Golden Retriever] Some studies suggest associations between grain-free diets, reduced taurine bioavailability, and DCM risk in certain breeds. Other studies have challenged the methodology of those reports or questioned the statistical strength of associations. At least one major epidemiological study in the field carries an expression of concern and a published correction. [Ambiguous - Dog - Golden Retriever] The evidence base is evolving. Peer-reviewed findings are mixed. No consensus has emerged.
How to Interpret Unsettled Evidence
Just Behaving approaches diet-associated DCM as an evolving evidence area that warrants caution but not certainty. We do not recommend grain-free diets for growing puppies, erring on the side of conservative dietary choices during a critical developmental window. We acknowledge that the full mechanism-if one exists-remains incompletely understood. We are skeptical of confident claims in either direction: claims that grain-free diets definitively cause DCM overstate the current evidence, and claims that diet-DCM associations are entirely debunked also overstate the evidence. Honest communication means acknowledging what we know and what we do not.
Chapter 5: What This Means for Your Family
Questions to Ask a Breeder
If you are acquiring a Golden Retriever puppy, these questions will help you understand the depth and rigor of a breeder's cardiac screening commitment:
What type of cardiac examination do you perform on breeding stock? A breeder should describe either auscultation by a board-certified veterinary cardiologist or, ideally, echocardiographic examination by a board-certified cardiologist. Auscultation alone by a general practitioner, while well-intentioned, is insufficient given the evidence presented above.
Who performed the examination? This matters. A board-certified veterinary cardiologist (credentials ending in "Diplomate, American College of Veterinary Internal Medicine, Specialty of Cardiology") has completed specialized training and passed rigorous credentialing exams. A general veterinarian has not. Both are competent veterinarians; only one has specialized expertise.
What was measured? If the examination included Doppler echocardiography, you should be able to ask what the measured peak aortic flow velocity was. "The vet said it sounded normal" is not the same as "the peak aortic velocity was 1.65 m/s." Numbers provide transparency; subjective clearance does not.
How old was the dog at screening? Because SAS can be progressive, a single screening at eight weeks is less informative than screening at eight weeks, six months, and two years. A breeder who screens once and calls it sufficient understands less about the condition than one who screens serially.
Have any puppies or dogs from your lines been diagnosed with heart disease? Breeders who have had cardiac issues emerge should describe how they responded: did they stop breeding the affected dog? The parents of the affected dog? Did they conduct additional screening? A breeder who encountered SAS and responded by removing affected dogs and their close relatives from breeding is behaving responsibly. A breeder who denies ever having encountered any cardiac issues across their entire breeding history might be screening insufficiently or being less than transparent.
Signs Your Family Should Watch For
Over the course of your dog's life, certain signs should prompt veterinary evaluation:
Exercise intolerance. A dog that tires unusually quickly during walks, play, or normal activity might be experiencing cardiac limitation. A young dog that lags behind playmates or seems unable to sustain activity deserves evaluation.
Syncope or collapse. Fainting or sudden loss of consciousness, even if brief and followed by full recovery, is a red flag for cardiac arrhythmia. This warrants immediate specialist evaluation.
Persistent cough not attributable to respiratory disease. Heart failure in dogs often manifests as a dry, persistent cough, particularly when the dog is resting or lying down. A cough that does not resolve with antibiotics might be cardiac in origin.
Blue-tinged mucous membranes (cyanosis). The gums, tongue, or membranes inside the mouth should be pink in a healthy dog. A bluish or purplish tint suggests inadequate oxygenation and warrants emergency evaluation.
Respiratory distress or shortness of breath. Labored breathing, panting at rest, or reluctance to lie down (because lying down worsens shortness of breath) can indicate pulmonary edema secondary to heart failure.
None of these signs are necessarily definitive for cardiac disease-they have other possible causes-but all warrant veterinary evaluation, ideally including echocardiographic assessment by a cardiologist if cardiac disease is suspected.
Diet and Lifestyle Considerations
Feed a high-quality diet with appropriate animal protein sources and, at least until your puppy is fully grown, avoid grain-free formulations. Discuss dietary recommendations with your veterinarian. Maintain appropriate body weight; obesity increases cardiac workload. Provide regular, moderate exercise appropriate to your dog's age and condition. Avoid extreme exercise in very young dogs (before growth plates have fully closed, typically around 18 months in large breeds) and avoid sudden spikes in activity level that might stress an underlying cardiac condition. Maintain routine veterinary care; your general practitioner can identify signs of cardiac disease and recommend specialist evaluation if indicated.
Chapter 6: What Just Behaving Does
Just Behaving's approach to cardiac screening is built on the evidence presented in this document. We recognize that screening is not a guarantee, but a risk reduction strategy grounded in the best available methodology.
All breeding dogs undergo echocardiographic evaluation by a board-certified veterinary cardiologist. We do not rely on auscultation by general practitioners, however well-intentioned. We measure peak aortic flow velocity and obtain quantitative data about left ventricular structure and function. We understand the distinction between normal, borderline, and affected, and we interpret results conservatively.
We re-screen periodically. Because SAS can be progressive, we do not treat a single normal measurement as a lifetime clearance. We screen breeding dogs before breeding and monitor them throughout their reproductive years.
Borderline results lead to deeper investigation, not dismissal. If a dog measures in the equivocal zone (velocities between 2.0-2.4 m/s), we repeat the examination, consider clinical context, and when in doubt, err on the side of caution in breeding decisions. We do not claim certainty where uncertainty exists.
We communicate results transparently. Families who purchase puppies from Just Behaving receive information about the cardiac screening of both parents, including measured velocities and cardiologist's interpretation. We do not claim that cardiac disease will not emerge-no responsible breeder can make that claim. We do claim that we have screened rigorously and removed high-risk dogs from our breeding program.
We counsel families about signs to watch for and dietary choices. Our relationship with families does not end at the curb. We provide information about what cardiac disease looks like, what to ask their veterinarian, and what choices (diet, exercise, monitoring) can support cardiac health. We encourage routine veterinary care and specialist evaluation if any concerning signs emerge.
Why This Matters
Cardiac disease in Golden Retrievers is not a rare anomaly that only affects a few unlucky families. It is also not a certainty-most Golden Retrievers live long, healthy lives. The truth is in the middle: a meaningful but manageable portion of the breed carries genetic predisposition for cardiac conditions, particularly SAS. The responsibility of a conscientious breeder is to reduce that risk through rigorous screening, transparent communication, and honest acknowledgment of what screening can and cannot accomplish.
Health screening is foundational to the Just Behaving philosophy. The Five Pillars-mentorship, calmness, structured leadership, prevention, and indirect correction-describe how to raise a well-mannered, functional family dog. But those pillars rest on a biological foundation. A puppy whose heart fails at age three cannot be mentored into maturity. A dog in cardiac distress cannot maintain the calmness that characterizes the JB approach. The heart comes first. Screening comes first. Then everything else that makes a family's life together possible.
Works Cited
Bagardi, M., et al. (2025). Transthoracic echocardiographic reference intervals in 214 adult Golden retrievers. Journal of Veterinary Medical Science, 87(4). DOI: 10.1292/jvms.24-00282
Bélanger, M. C., Côté, É., & Beauchamp, G. (2014). Association between Aortoseptal Angle in Golden Retriever Puppies and Subaortic Stenosis in Adulthood. Journal of Veterinary Internal Medicine, 28(5), 1498-1503. DOI: 10.1111/jvim.12390
Bélanger, M. C., Ouellet, M., Queney, G., & Moreau, M. (2005). Taurine-deficient dilated cardiomyopathy in a family of golden retrievers. Journal of the American Animal Hospital Association, 41(5), 284-291. DOI: 10.5326/0410284
Javard, R., Bélanger, M. C., Côté, É., Beauchamp, G., & Pibarot, P. (2014). Comparison of peak flow velocity through the left ventricular outflow tract and effective orifice area indexed to body surface area in Golden Retriever puppies. Journal of the American Veterinary Medical Association, 245(12), 1367-1374. DOI: 10.2460/javma.245.12.1367
Kaplan, J. L., Stern, J. A., Fascetti, A. J., et al. (2018). Taurine deficiency and dilated cardiomyopathy in golden retrievers fed commercial diets. PLOS ONE, 13(12), e0209112. DOI: 10.1371/journal.pone.0209112
Kienle, R. D., Thomas, W. P., & Pion, P. D. (1994). The natural clinical history of canine congenital subaortic stenosis. Journal of Veterinary Internal Medicine, 8(6), 423-431. DOI: 10.1111/j.1939-1676.1994.tb03262.x
Ontiveros, E. S., Fousse, S. L., Crofton, A. E., et al. (2019). Congenital Cardiac Outflow Tract Abnormalities in Dogs: Prevalence and Pattern of Inheritance From 2008 to 2017. Frontiers in Veterinary Science, 6, Article 52. DOI: 10.3389/fvets.2019.00052
Ontiveros, E. S., Keene, B. W., Napoli, A., et al. (2020). Development of plasma and whole blood taurine reference ranges and identification of dietary features associated with taurine deficiency and dilated cardiomyopathy in golden retrievers: A prospective, observational study. PLOS ONE, 15(6), e0234779. DOI: 10.1371/journal.pone.0234779. Note: Expression of concern and correction published.
Pradelli, D., et al. (2014). The Influence of Emotional Stress on Doppler-derived Aortic Peak Velocity in Boxer Dogs. Journal of Veterinary Internal Medicine, 28(6), 1724-1730. DOI: 10.1111/jvim.12434
Stern, J. A., Meurs, K. M., Nelson, O. L., Lahmers, S. M., & Lehmkuhl, L. B. (2012). Familial subvalvular aortic stenosis in golden retrievers: inheritance and echocardiographic findings. Journal of Small Animal Practice, 53(4), 213-216. DOI: 10.1111/j.1748-5827.2011.01187.x
U.S. Food and Drug Administration. (2022). FDA Investigation into Potential Link between Certain Diets and Canine Dilated Cardiomyopathy. Retrieved from https://www.fda.gov/animal-veterinary/outbreaks-and-recalls/fda-investigation-potential-link-between-certain-diets-and-canine-dilated-cardiomyopathy
van Staveren, M. D. B., et al. (2020). Detecting and recording cardiac murmurs in clinically healthy puppies in first opinion veterinary practice. Veterinary Sciences, 7(2), 57. DOI: 10.3390/vetsci7020057